Publications by authors named "Yeong-Ran Ahn"

Claim this Profile
U
Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer.
Kevin H Lin, Justine C Rutter, Abigail Xie, Bryann Pardieu, Emily T Winn, Yeong-Ran Ahn

Nat Genet· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity.
Kevin H Lin, Abigail Xie, Justine C Rutter, Yeong-Ran Ahn, Julia M Lloyd-Cowden

Cell Metab· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors.
Gray R Anderson, Suzanne E Wardell, Merve Cakir, Catherine Yip, Yeong-Ran Ahn

Nat Commun· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases toxicity of PARP inhibition by preventing Rad51 foci formation in wild type high-grade serous ovarian cancer.
Ethan Brill, Takuhei Yokoyama, Jayakumar Nair, Minshu Yu, Yeong-Ran Ahn

Oncotarget· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis